The landscape of neurodegenerative disease diagnostics underwent a significant shift on February 27, 2026, with the publication of a landmark…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
New Blood Test Paradigm for Alzheimer’s Disease Detection Focuses on Protein Structure Rather Than Concentration
The landscape of neurodegenerative diagnostics is undergoing a fundamental shift as researchers move beyond simple protein quantification to investigate the…
Read More
Washington University Researchers Develop p-tau217 Blood Test Clock Capable of Predicting Alzheimer’s Symptom Onset Years in Advance
In a significant advancement for neurodegenerative disease research, scientists at Washington University School of Medicine in St. Louis have pioneered…
Read More
A Groundbreaking DNA Test from Hebrew University Revolutionizes Leishmaniasis Tracking and Global Disease Surveillance.
The Hebrew University of Jerusalem has unveiled a pioneering molecular diagnostic system, spearheaded by researchers at its Koret School of…
Read More
Revolutionary Blood Test Model Forecasts Alzheimer’s Symptom Onset, Reshaping Early Detection and Clinical Trial Strategies
Clinical laboratories across the globe are keenly observing a pivotal shift in neurodegenerative disease diagnostics, particularly with the escalating prominence…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
Clinical laboratory leaders faced a critical, albeit narrowing, window to influence a significant new federal anti-fraud initiative launched by the…
Read More
